The hypoglycemic Ayurvedic herb
- Helps suppress sugar cravings naturally
- Promotes cardiovascular health
- Helps maintain normal insulin levels
- Supports healthy glucose metabolism
$41.19 — or subscribe and get 20% off
Gymnema sylvestre is a woody branched vine growing in the wild forests of Central and South India. The plant has been used in traditional Ayurvedic medicine for centuries for many different conditions, but is mainly known for enhancing blood sugar metabolism. It does this by reducing glucose absorption from the intestines and increasing peripheral insulin sensitivity, and some evidence even suggests that it may support the body’s ability to produce its own insulin by helping to repair the cells in the pancreas that make it. Clinical trials have found that gymnema can lower blood glucose and decrease the need for insulin in both insulin-dependent (type 1) and insulin-independent (type 2) diabetes.
Balancing blood sugar will help not only to manage diabetes but also to reduce weight gain. When used as a mouthwash, gymnema inhibits the sensation of sweetness by interfering with the tongue’s sugar receptors. Gymnema has been found to lower blood lipids in diabetic subjects and it also inhibits the growth of Candida albicans, an opportunistic fungus that is known to cause a wide array of health issues.
AOR’s Gymnema-75 is an evidence-based, high dose extract of Gymnema sylvestre. Those looking for a natural support for blood sugar management and candida control will benefit from supplementing with this ancient Indian herb. Gymnema sylvestre has a long and well recognized history in Ayurvedic medicine of being effective in lowering elevated blood sugar levels by helping to support healthy glucose metabolism.
Gymnema-75 is a high-potency extract of Gymnema sylvestre, an herb used in traditional Ayurvedic medicine to help promote digestion.
AOR™ guarantees that all ingredients have been declared on the label. Contains no wheat, gluten, corn, nuts, peanuts, sesame seeds, sulphites, mustard, soy, dairy, eggs, fish, shellfish or any animal by product.
Take one capsule daily with food, two hours before or after taking other medications, or as directed by a qualified health care practitioner.
Do not use if pregnant or breastfeeding. Consult a health care practitioner prior to use if you have diabetes, intestinal disorders or symptoms such as abdominal pain, nausea, vomiting or fever.
- Cardiovascular health
The information and product descriptions appearing on this website are for information purposes only, and are not intended to provide or replace medical advice to individuals from a qualified health care professional. Consult with your physician if you have any health concerns, and before initiating any new diet, exercise, supplement, or other lifestyle changes.
*Contains 225 mg gymnemic acids
Non-medicinal Ingredients: Sodium benzoate.
Note: Herbal extracts will naturally vary in color from one batch to another.
Reduces Blood Glucose, HbA1c, and Medication Requirements
In human clinical trials, Gymnema extracts were effective in patients with unhealthy blood sugar levels. In 22 patients, Gymnema extract resulted in a significant reduction in blood glucose, and in sugar-modified haemoglobin and plasma proteins. 5 of the 22 patients were able to discontinue their standard medications and maintain healthy blood glucose levels with Gymnema alone.
Repairs Beta Cells in the Pancreas
Similar results were found in a study of 27 patients receiving therapy for unhealthy blood sugar levels. The Gymnema, along with its other effects, reduced the requirements for insulin and brought serum lipids to almost normal levels. The Gymnema extract appeared to enhance the body’s own insulin, possibly by regenerating or repairing beta cells which produce insulin.
Glucose Receptor Modulation
More recent studies suggest that the GS may inhibit the release of Gastro-Intestinal Peptide (G.I.P.), which normally occurs following duodenal infusion of glucose. In addition to reducing the insulinotropic action of gastro-intestinal hormones, GS is thought to increase peripheral insulin sensitivity. This might then result in lowered insulin levels during a glucose tolerance test. The mechanism of action may be via the interaction with the glucose receptor. This may explain the folklore claims of loss of sweet sensation following chewing of GS leaves. In fact, GS is considered a carbohydrate metabolism modifier and has the following properties:
(1) Sensation of taste. The tongue sugar receptors are effectively blocked by GS, thereby inhibiting sensation of sweetness.
(2) Glucose Control. Inhibition of uptake of glucose in the intestines by interacting with and blocking the glucose receptor sites, thereby reducing the “spike” in glucose and insulin seen after a meal.
The active ingredients are thought to be saponin and glycoside derivatives. So far, eleven different types have been isolated and identified as gymnemic acids. The chemical structure has been identified by nuclear magnetic resonance and X-ray studies to be similar to glycuronides.
- Bone K. Gymnema: a key herb in the management of diabetes. Port Townsend, WA: Townsend Letter for Doctors and Patients; 2002. Available from: townsendletter.com/Dec2002/phytotherapy1202.htm.
- Leach MJ. Gymnema sylvestre for Diabetes Mellitus: A Systematic Review. J Alt Comp Med. 2007; 13(9): 997-983.
- Shanmugasundaram E, Gopinath K, Shanmugasundaram K, Rajendran V. Possible regeneration of the Islets of Langerhans in Streptozotocin-diabetic rats given Gymnema sylvestre leaf extracts. J Ethnopharmacol 1990;30:265–279.
- Joffe D. Gymnema sylvestre lowers HbA1c. Diabetes Control Newslett 2001;76:unnumbered page.
- Baskaran K, Kizar Ahamath B, Radha Shanmugasundaram K, Shanmugasundaram ER. Antidiabetic effect of a leaf extract from Gymnema sylvestre in non-insulin-dependent diabetes mellitus patients. J Ethnopharmacol. 1990 Oct; 30(3): 295-300.
- Shanmugasundaram ER, Rajeswari G, Baskaran K, Rajesh Kumar BR, Radha Shanmugasundaram K, Kizar Ahmath B. Use of Gymnema sylvestre leaf extract in the control of blood glucose in insulin-dependent diabetes mellitus. J Ethnopharmacol. 1990 Oct; 30(3): 281-94.